Abstract:BACKGROUND:Epithelial-to-mesenchymal transition (EMT) is involved in pathogenesis of human benign prostatic hyperplasia (BPH). Estrogenic signaling pathways may stimulate the induction of EMT. However, the details of estradiol (E2) and estrogen receptors (ERs) effects on EMT, as well as E2-induced modulation of benign prostatic epithelial cell phenotype in vitro have not been completely clarified. METHODS:The effects of E2 on EMT markers and cytokeratins (CKs) expression were evaluated in benign epithelial cell lines BPH-1 and RWPE-1, which were cultured both in two-dimensional (2D) culture and three-dimensional (3D) culture model using hanging drop technique or 3D Matrigel model. ER antagonist, ICI182,780, was used to confirm the regulatory effects of E2 on EMT and phenotypic modulation. In 3D culture, immunohistochemical stainings were performed to detect the specific phenotype of cells that underwent EMT in acinar-like spheroids formed by RWPE-1. To illustrate the exact function of ERs in E2-induced EMT and phenotypic modulation, specific short interfering RNAs (siRNAs), and agonists were used to knockdown or activate individual ERs, respectively. RESULTS:E2-induced EMT was observed both in 2D and 3D culture, with related regulation of EMT markers expression at both mRNA and protein level. In addition, E2 down-regulated luminal cell type markers CK18 and CK8 and up-regulated basal cell type markers CK5 and CK14. E2 also increased intermediate type markers CK15 and CK17, while it attenuated CK19 in 3D culture. ICI182,780 blocked E2-induced EMT and cell phenotypic switching. In 3D Matrigel culture, Vimentin was co-expressed with ERα and CK17, as well as with SMemb, which is related to cell status switching and proliferation. Knockdown of ERα but not GPR30 inhibited EMT, while ERβ knockdown facilitated EMT process. Knockdown of ERα blocked E2-induced EMT both in RWPE-1 and BPH-1. MRNA expression of EMT markers was stimulated by ERα-specific agonist PPT and inhibited by ERβ-specific agonist DPN. CONCLUSIONS:Estrogenic effect mediated by ERα can promote EMT. E2 is also an inductive factor of cell phenotypic switching. Cell type modulation is associated with E2-induced EMT in benign prostatic epithelial cells. Taken together the results support a contribution of estrogens to the pathogenesis of BPH in elderly men.

Prostaglandin E2 switches from a stimulator to an inhibitor of cell migration after epithelial-to-mesenchymal transition.

Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.

Prostaglandin E2 is a Potent Inhibitor of Epithelial-to-mesenchymal Transition: Interaction with Hepatocyte Growth Factor.

Prostaglandin E 2 is a potent inhibitor of epithelial-to-mesenchymal transition : interaction with hepatocyte growth factor

Prostaglandin D2 Inhibits TGF-beta1-induced Epithelial-to-mesenchymal Transition in MDCK Cells.

PGE2 Promotes the Migration of Mesenchymal Stem Cells Through the Activation of FAK and ERK1/2 Pathway

Role of the Prostaglandin E2/E-prostanoid 2 Receptor Signalling Pathway in TGFβ-induced Mice Mesangial Cell Damage.

Prostaglandin E2 serves a dual role in regulating the migration of dendritic cells

Effects of Epidermal Growth Factor on Transforming Growth Factor-Beta1-induced Epithelial-Mesenchymal Transition and Potential Mechanism in Human Corneal Epithelial Cells.

Prostaglandin D-2 Inhibits Fibroblast Migration

Up-regulation of MMP-2 Expression by Estradiol via TGFβ1 in Prostate Stromal Cells

Prostaglandins in Cancer Cell Adhesion, Migration, and Invasion

Role of the Prostaglandin E2 Receptor Agonists in TGF-β1-induced Mesangial Cell Damage.

Role of Prostaglandin Receptor EP2 in the Regulations of Cancer Cell Proliferation, Invasion, and Inflammation

Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts.

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway

Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels.

Prostaglandin E2 (PGE2) Promotes Proliferation and Invasion by Enhancing SUMO-1 Activity Via EP4 Receptor in Endometrial Cancer.

Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.

Prostaglandin E2 Induces Stromal Cell-Derived Factor-1 Expression in Prostate Stromal Cells by Activating Protein Kinase A and Transcription Factor Sp1.